
Michael D. Anderson
Examiner (ID: 10390, Phone: (571)270-5159 , Office: P/2433 )
| Most Active Art Unit | 2433 |
| Art Unit(s) | 2498, 2433, 2432 |
| Total Applications | 759 |
| Issued Applications | 575 |
| Pending Applications | 52 |
| Abandoned Applications | 146 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11395200
[patent_doc_number] => 20170015735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'ANTI-GLUCOSAMINIDASE PASSIVE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/283901
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18235
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15283901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/283901 | Anti-glucosaminidase passive immunization for Staphylococcus aureus infections | Oct 2, 2016 | Issued |
Array
(
[id] => 11527269
[patent_doc_number] => 20170087246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/276922
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32833
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276922 | Modular antigen transportation molecules and uses thereof in animals | Sep 26, 2016 | Issued |
Array
(
[id] => 11879647
[patent_doc_number] => 09750802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 15/270034
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 45445
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15270034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/270034 | Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases | Sep 19, 2016 | Issued |
Array
(
[id] => 11362891
[patent_doc_number] => 20170000872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'INACTIVATED BACTERIAL CELL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/268276
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13895
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268276
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268276 | Inactivated bacterial cell formulation | Sep 15, 2016 | Issued |
Array
(
[id] => 13386385
[patent_doc_number] => 20180244734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => NOVEL PROTEINS AND DETECTION METHODS
[patent_app_type] => utility
[patent_app_number] => 15/755371
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755371 | NOVEL PROTEINS AND DETECTION METHODS | Aug 30, 2016 | Abandoned |
Array
(
[id] => 13574967
[patent_doc_number] => 20180339032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => APPLICATION OF GENETICALLY GENINEERED BACTERIUM OF ATTENUATED SALMONELLA TYPHIMURIUM IN PREPARATION OF MEDICINE FOR TREATMENT OF LIVER CANCER
[patent_app_type] => utility
[patent_app_number] => 15/755537
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755537
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755537 | APPLICATION OF GENETICALLY GENINEERED BACTERIUM OF ATTENUATED SALMONELLA TYPHIMURIUM IN PREPARATION OF MEDICINE FOR TREATMENT OF LIVER CANCER | Aug 16, 2016 | Abandoned |
Array
(
[id] => 11836709
[patent_doc_number] => 20170218429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'PRETREATMENT METHOD FOR BACTERIAL IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING OF POSITIVE BLOOD CULTURE SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 15/235950
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2772
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/235950 | Pretreatment method for bacterial identification and antimicrobial susceptibility testing of positive blood culture samples | Aug 11, 2016 | Issued |
Array
(
[id] => 16275596
[patent_doc_number] => 10758603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Composition for preventing and treating
[patent_app_type] => utility
[patent_app_number] => 16/320515
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7044
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320515 | Composition for preventing and treating | Aug 8, 2016 | Issued |
Array
(
[id] => 11289132
[patent_doc_number] => 20160339064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Method and System for Treating Cancer Cachexia'
[patent_app_type] => utility
[patent_app_number] => 15/228454
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18910
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/228454 | Method and system for treating cancer cachexia | Aug 3, 2016 | Issued |
Array
(
[id] => 13733181
[patent_doc_number] => 20180371058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => IMPROVED MICROBE-BINDING MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/750788
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750788 | Microbe-binding molecules and uses thereof | Aug 3, 2016 | Issued |
Array
(
[id] => 16680748
[patent_doc_number] => 10940204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Peptides and antibodies for the removal of biofilms
[patent_app_type] => utility
[patent_app_number] => 15/744713
[patent_app_country] => US
[patent_app_date] => 2016-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 42
[patent_no_of_words] => 51591
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744713 | Peptides and antibodies for the removal of biofilms | Jul 31, 2016 | Issued |
Array
(
[id] => 15423055
[patent_doc_number] => 10544443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Detection of bacteria using bacteriophage
[patent_app_type] => utility
[patent_app_number] => 15/748490
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4607
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748490 | Detection of bacteria using bacteriophage | Jul 28, 2016 | Issued |
Array
(
[id] => 17073780
[patent_doc_number] => 11110159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Methods for inducing an immune response
[patent_app_type] => utility
[patent_app_number] => 15/747671
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 25124
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747671
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747671 | Methods for inducing an immune response | Jul 24, 2016 | Issued |
Array
(
[id] => 11381635
[patent_doc_number] => 20170007691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/216015
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23059
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15216015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/216015 | Composition for inducing proliferation or accumulation of regulatory T cells | Jul 20, 2016 | Issued |
Array
(
[id] => 15099631
[patent_doc_number] => 10471110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Bifidobacteria for treating cardiac conditions
[patent_app_type] => utility
[patent_app_number] => 15/744211
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8375
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744211 | Bifidobacteria for treating cardiac conditions | Jul 6, 2016 | Issued |
Array
(
[id] => 14057899
[patent_doc_number] => 10233233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Lipopolysaccharide-targeted peptide mimic vaccine against Q fever
[patent_app_type] => utility
[patent_app_number] => 15/195586
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 12462
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15195586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/195586 | Lipopolysaccharide-targeted peptide mimic vaccine against Q fever | Jun 27, 2016 | Issued |
Array
(
[id] => 12191719
[patent_doc_number] => 09895433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Interferon-β production modulating listeria strains and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 15/192757
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16897
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15192757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/192757 | Interferon-β production modulating listeria strains and methods for using same | Jun 23, 2016 | Issued |
Array
(
[id] => 11350233
[patent_doc_number] => 20160368972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein'
[patent_app_type] => utility
[patent_app_number] => 15/191739
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 58065
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/191739 | Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein | Jun 23, 2016 | Issued |
Array
(
[id] => 12750529
[patent_doc_number] => 20180142010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHOD FOR TREATING A PATIENT IN COMPLIANCE WITH VACCINATION WITH ECULIZUMAB OR AN ECULIZUMAB VARIANT
[patent_app_type] => utility
[patent_app_number] => 15/580760
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580760 | METHOD FOR TREATING A PATIENT IN COMPLIANCE WITH VACCINATION WITH ECULIZUMAB OR AN ECULIZUMAB VARIANT | Jun 21, 2016 | Abandoned |
Array
(
[id] => 16370273
[patent_doc_number] => 10802021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Synthetic hybrid receptor and genetic circuit in bacteria to detect enteric pathogenic microorganisms
[patent_app_type] => utility
[patent_app_number] => 15/580845
[patent_app_country] => US
[patent_app_date] => 2016-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 12364
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580845
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580845 | Synthetic hybrid receptor and genetic circuit in bacteria to detect enteric pathogenic microorganisms | Jun 8, 2016 | Issued |